What medication can be given to treat severe bradycardia (heart rate 35 bpm) in a patient before dialysis?

Treatment of Severe Bradycardia (35 bpm) Before Dialysis

For a patient with severe bradycardia at 35 bpm before dialysis, atropine 0.5-1 mg IV is the first-line medication, which can be repeated every 3-5 minutes up to a maximum dose of 3 mg if the patient is symptomatic or hemodynamically compromised. 1

Initial Assessment and First-Line Treatment

Atropine as Primary Agent

• Atropine is reasonable (Class IIa recommendation) for symptomatic bradycardia or hemodynamic compromise, working by blocking muscarinic acetylcholine receptors to increase sinus node automaticity 1
• Dosing: 0.5-1 mg IV bolus, repeated every 3-5 minutes to maximum 3 mg total 1
• Onset is rapid with a half-life of approximately 2 hours 1
• Important caveat: Doses <0.5 mg can paradoxically worsen bradycardia, so avoid underdosing 1

Critical Consideration for Dialysis Patients

• In the dialysis context, be aware of BRASH syndrome (Bradycardia, Renal failure, AV nodal blockers, Shock, Hyperkalemia), which can cause atropine-resistant bradycardia 2, 3
• If the patient is on beta-blockers, calcium channel blockers, or other AV nodal blocking agents, atropine may be ineffective 2, 3
• Check potassium level immediately - hyperkalemia commonly contributes to bradycardia in dialysis patients and creates a synergistic cycle 2, 3

Second-Line Agents if Atropine Fails

Beta-Adrenergic Agonists (Class IIb)

If atropine is ineffective and the patient has low likelihood of coronary ischemia, consider 1:

• Dopamine: 5-20 mcg/kg/min IV, starting at 5 mcg/kg/min and increasing by 5 mcg/kg/min every 2 minutes 1

  • Monitor closely as doses >20 mcg/kg/min can cause vasoconstriction and arrhythmias 1
  • Successfully used in BRASH syndrome cases when atropine failed 2

• Isoproterenol: 20-60 mcg IV bolus or 1-20 mcg/min infusion titrated to heart rate response 1

  • Pure beta-agonist without vasopressor effect 1
  • Effective in BRASH syndrome after atropine failure 3

• Epinephrine: 2-10 mcg/min IV or 0.1-0.5 mcg/kg/min IV titrated to effect 1

Special Considerations for Dialysis Setting

Medication-Related Causes

• Review and hold all AV nodal blocking agents (beta-blockers, calcium channel blockers, digoxin) as these synergize with renal failure and hyperkalemia 2, 3
• Fomepizole during dialysis can cause severe bradycardia, though this is rare 4

Hyperkalemia Management

• If potassium is elevated, treat aggressively with calcium gluconate, insulin/glucose, and urgent dialysis - this addresses a root cause rather than just treating the symptom 2, 3
• The bradycardia may be refractory to chronotropic agents until hyperkalemia is corrected 2, 3

Temporary Pacing Consideration

• If bradycardia is refractory to medical therapy with ongoing hemodynamic compromise, temporary transvenous pacing is reasonable (Class IIa) 1
• Transcutaneous pacing may be considered as a bridge (Class IIb), though sustained electrical capture occurs in only ~10% of cases 1, 5

Common Pitfalls to Avoid

• Do not use atropine doses <0.5 mg - this can worsen bradycardia through paradoxical effects 1
• Do not use atropine in heart transplant patients without evidence of autonomic reinnervation (Class III: Harm) 1
• Do not overlook reversible causes: Check medications, electrolytes (especially potassium), and thyroid function before assuming permanent pacing is needed 1
• Monitor for ischemia when using beta-agonists - these agents increase myocardial oxygen consumption 1